In vitro Antifungal Activity of Ravuconazole Against Isolates of Dermatophytes and Candida Species from Patients with Dermatomycoses: Comparison with Two Oral Antifungal Drugs Approved for the Systemic Treatment of Intractable Forms of the Diseases